Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatic steatosis in genotype 4 chronic hepatitis C patients: implication for therapy.

Journal of clinical gastroenterology - 1 Jan 2000

Khattab Mahmoud Aboelneen, Abdel-fattah Mohammed Emad, Eslam Mohammed, Abdelaleem Asharf, Abdelaleem Rabab Atef, Shatat Mohammed, Ali Ahmed, Hamdy Lamia, Tawfek Heba

Abstract excerpt

BACKGROUND AND AIM: The association of hepatitis C virus genotype 4 (HCV-4) with hepatic steatosis has not been clarified. We aimed to determine the parameters associated with steatosis among HCV-4 patients and to assess the effect of steatosis on treatment with peginterferon and ribavirin. METHODS: In a prospective study; 131 nondiabetic genotype 4 CHC patients were enrolled for analysis, treated with...

Topics

Join the communities discussing this publication.

Cholesterol
Egypt
Fatty Liver
Interferon-alpha
Interferon alpha-2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Polyethylene Glycols

Waist Circumference

Source

Identifiers

PMID: 20195166
DOI: 10.1097/MCG.0b013e3181d2ef1a

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatic steatosis in genotype 4 chronic hepatitis C patients: implication for therapy.PMID 20195166Read ↗

Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors.Semantic proximity Read ↗

Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin.Semantic proximity Read ↗

Improvement of steatosis after interferon therapy in HCV genotype 4 is related to weight loss.Semantic proximity Read ↗

Prevalence and impact of hepatic steatosis on the response to antiviral therapy in Saudi patients with genotypes 1 and 4 chronic hepatitis C.Semantic proximity Read ↗

The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4.Semantic proximity Read ↗

Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.Semantic proximity Read ↗

Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.Semantic proximity Read ↗

Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks.Semantic proximity Read ↗

Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients.Semantic proximity Read ↗

Hepatic steatosis in Iranian patients with chronic hepatitis C.Semantic proximity Read ↗

Serum lipids and chronic hepatitis C genotype 4: interaction and significance.Semantic proximity Read ↗

PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.